MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 235 filers reported holding MYRIAD GENETICS INC in Q3 2015. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $54,411,000 | -5.2% | 3,264,023 | +17.0% | 0.01% | -16.7% |
Q3 2016 | $57,423,000 | -29.5% | 2,790,235 | +4.8% | 0.01% | -33.3% |
Q2 2016 | $81,487,000 | -20.3% | 2,662,989 | -2.5% | 0.02% | -25.0% |
Q1 2016 | $102,218,000 | -10.9% | 2,730,915 | +2.7% | 0.02% | -7.7% |
Q4 2015 | $114,757,000 | +9.9% | 2,658,881 | -4.6% | 0.03% | -3.7% |
Q3 2015 | $104,456,000 | +12.7% | 2,786,972 | +2.2% | 0.03% | +22.7% |
Q2 2015 | $92,712,000 | +62.1% | 2,727,612 | +68.8% | 0.02% | +57.1% |
Q1 2015 | $57,207,000 | +13.4% | 1,616,019 | +9.1% | 0.01% | +16.7% |
Q4 2014 | $50,435,000 | -12.3% | 1,480,758 | -0.7% | 0.01% | -25.0% |
Q3 2014 | $57,499,000 | +0.7% | 1,490,775 | +1.6% | 0.02% | 0.0% |
Q2 2014 | $57,113,000 | +11.8% | 1,467,442 | -1.8% | 0.02% | +6.7% |
Q1 2014 | $51,091,000 | +68.8% | 1,494,328 | +3.6% | 0.02% | +66.7% |
Q4 2013 | $30,263,000 | -11.7% | 1,442,462 | -1.0% | 0.01% | -25.0% |
Q3 2013 | $34,254,000 | +0.0% | 1,457,633 | +14.4% | 0.01% | -7.7% |
Q2 2013 | $34,237,000 | – | 1,274,183 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |